Frilasita Aisyah Yudhaputri, Mbiomedsc
Frilasita Aisyah Yudhaputri, Mbiomedsc
Frilasita Aisyah Yudhaputri, Mbiomedsc
Pendidikan
S1 Biologi Molekuler – Universitas Indonesia
S2 Biomedical Science – Monash University Australia
1
Simulasi Pemeriksaan rRTPCR
SARS CoV 2
Webinar PATELKI 8
Jakarta, 13 Juni 2020
COVID-19 Molecular Testing
Confirmation of cases of COVID-19 is based on detection of unique sequences
of SARS-CoV2 RNA in Clinical specimen by NAAT such as real-time reverse-
transcription polymerase chain reaction
OUTLINE
• Biological sample Collection and processing
• Viral RNA Extraction
• real-time reverse-transcription polymerase chain reaction
• Result Interpretation
3
Biological sample Collection and processing
4
Sethurahman, et al. 2020
Biological sample Collection and processing (Cont)
Reccomended Specimen type
• Upper Respiratory
NP, OP, Nasal Swab, Naso wash
• Lower repiratory
Sputum dan BAL
https://coronavirusexplained.ukri.org/en/article/vdt0006/
5
Wang et al., 2020
Human Cell has DNA as the genetic material that passes information
7
Trizol
The Key to Succesful NAAT –
SARS-CoV-2 Nucleic Acid Extraction
COVID-19 Testing by Molecular must be carried out in accordance with
biosafety regulations following National, WHO / US-CDC guideline
recommendations
8
SARS-CoV-2 Structure
• (+) stranded RNA virus, 27- 32 kb
• Crown Like (TEM)
• 4 active protein: S,M, E, N
• RdRP gene (RNA-dependent RNA Polymerase) is
conserved
Gen RdRP
REFERENCES
SARS-CoV-2 (COVID-19) Detection
Development and methods are Subject to change
• 17 January 2020 à Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR – Charité, Berlin
Germany
• 23 January 2020 à Detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by RT-PCR – Hong
Kong University
• 24 January 2020 à China CDC Primers and probes for detection 2019-nCoV
• 24 January 2020 à PCR and sequencing protocols for 2019-nCoV- National Institute of Infectious Diseases Japan
• 28 January 2020 à PCR and sequencing protocol for 2019-nCoV - Department of Medical Sciences, Ministry of
Public Health, Thailand
• 28 January 2020 à US CDC panel primer and probes– U.S. CDC, USAV – U.S. CDC, USA
• 28 January 2020 à US CDC panel primer and probes– U.S. CDC, USA
https://www.cdc.gov/coronavirus/2019-nCoV/lab/index.html
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance
SARS-CoV-2 rRTPCR
• SAR-CoV-2 has RNA as their material
genetic à need to convert RNA to DNA Specific site
(Reverse Transcription)
• Positive Control
• Negative Control/NTC (no template RNA/DNA)
• Internal amplification control (probe)
• Human Specimen Extraction Control (HSC)
Corrective Action
False Positive/False Negative Prevention
CLSI MM3-2A Approved guidelines 2003 12
Master Mix Preparation Simulation
13
©Biology With Animation
Samples Controls
©Biology With 16
Animation
How To
Interprete
Result?
17
False negative and False positive
Result
• False negatives caused by
o Specimen collection timing
o Poor handling or poor quality of specimen
o Strain variation
o Assay inhibition
(blood, ethanol, wooden stick, calcium alginate swab)
Courtesy : MetroTV
Masa akhir wabah ini belum dapat di ramalkan
dengan pasti, maka kita harus tetap waspada
21